ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,326,274 | -10.0% | 47,350 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $1,474,230 | +1.0% | 47,100 | -9.0% | 0.00% | 0.0% |
| Q1 2023 | $1,459,114 | +7.9% | 51,760 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,352,489 | +1.2% | 51,760 | -13.5% | 0.00% | 0.0% |
| Q3 2022 | $1,336,000 | -25.1% | 59,850 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $1,783,000 | +8.9% | 59,850 | -3.9% | 0.00% | +33.3% |
| Q1 2022 | $1,638,000 | +1.0% | 62,270 | -10.7% | 0.00% | 0.0% |
| Q4 2021 | $1,622,000 | -57.1% | 69,730 | -43.1% | 0.00% | -57.1% |
| Q3 2021 | $3,779,000 | +25.8% | 122,539 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $3,005,000 | -17.4% | 122,539 | -37.1% | 0.01% | -14.3% |
| Q1 2021 | $3,638,000 | -13.4% | 194,735 | -7.6% | 0.01% | -22.2% |
| Q4 2020 | $4,203,000 | +20.4% | 210,685 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $3,491,000 | -14.6% | 210,685 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $4,088,000 | +35.0% | 210,685 | +0.3% | 0.01% | +11.1% |
| Q1 2020 | $3,029,000 | -29.1% | 210,022 | +0.3% | 0.01% | -10.0% |
| Q4 2019 | $4,272,000 | +0.4% | 209,433 | -3.9% | 0.01% | -9.1% |
| Q3 2019 | $4,253,000 | -13.4% | 217,974 | 0.0% | 0.01% | -15.4% |
| Q2 2019 | $4,913,000 | -41.6% | 217,974 | -5.5% | 0.01% | -40.9% |
| Q1 2019 | $8,416,000 | +31.3% | 230,647 | +6.2% | 0.02% | +15.8% |
| Q4 2018 | $6,410,000 | -28.7% | 217,211 | +2.6% | 0.02% | -17.4% |
| Q3 2018 | $8,988,000 | +3.1% | 211,791 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $8,717,000 | -28.9% | 211,791 | +0.1% | 0.02% | -32.4% |
| Q1 2018 | $12,266,000 | +4.6% | 211,631 | -1.3% | 0.03% | +9.7% |
| Q4 2017 | $11,730,000 | +8.6% | 214,324 | +0.9% | 0.03% | +6.9% |
| Q3 2017 | $10,802,000 | -12.1% | 212,477 | +0.3% | 0.03% | -17.1% |
| Q2 2017 | $12,285,000 | -0.3% | 211,927 | +0.6% | 0.04% | -2.8% |
| Q1 2017 | $12,323,000 | +2.4% | 210,650 | -2.7% | 0.04% | 0.0% |
| Q4 2016 | $12,036,000 | +17.4% | 216,560 | -0.7% | 0.04% | +12.5% |
| Q3 2016 | $10,253,000 | +8.5% | 218,016 | -0.2% | 0.03% | +6.7% |
| Q2 2016 | $9,446,000 | +44.1% | 218,556 | +14.0% | 0.03% | +20.0% |
| Q1 2016 | $6,554,000 | -58.2% | 191,694 | -2.9% | 0.02% | -56.9% |
| Q4 2015 | $15,676,000 | +36.5% | 197,484 | +0.9% | 0.06% | +31.8% |
| Q3 2015 | $11,488,000 | -7.4% | 195,803 | +1.6% | 0.04% | 0.0% |
| Q2 2015 | $12,402,000 | +8.4% | 192,757 | +2.7% | 0.04% | +12.8% |
| Q1 2015 | $11,446,000 | +0.7% | 187,724 | -3.3% | 0.04% | +8.3% |
| Q4 2014 | $11,372,000 | +37.1% | 194,197 | +0.4% | 0.04% | +33.3% |
| Q3 2014 | $8,293,000 | -14.3% | 193,443 | +0.6% | 0.03% | -12.9% |
| Q2 2014 | $9,677,000 | +25.4% | 192,278 | +9.9% | 0.03% | +24.0% |
| Q1 2014 | $7,715,000 | +6.8% | 174,984 | -1.5% | 0.02% | +13.6% |
| Q4 2013 | $7,225,000 | +32.6% | 177,697 | +9.6% | 0.02% | +22.2% |
| Q3 2013 | $5,450,000 | +40.3% | 162,113 | +19.7% | 0.02% | +38.5% |
| Q2 2013 | $3,885,000 | – | 135,451 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |